Alcoholism Drug Fights Cancer

Print Friendly, PDF & Email

An old drug prescribed to help people stop drinking alcohol may be an effective cancer-killer, according to new study.

The drug, Antabuse, appears to ‘freeze’ cancer in place, preventing them from getting rid of waste, which, ultimately, kills them.

Danish and Czech researchers tested the drug in live mice and human cancer cells and found that it was effective in both without harming other cells.

These findings are not enough to indicate how Antabuse would behave in living people, but the drug is already FDA-approved and its patent is long expired, so if further testing is as promising as this study’s findings, the drug could someday be a cheap alternative cancer treatment.

The new study found that Antabuse effectively 'froze' breast cancer cells as well as those of prostate, colon and other cancers, eventually killing them 

Scientists were first tipped off to the Antabuse’s potential power against cancer by a series of unfortunate coincidences documented in a 1971 case study.

Doctors prescribed the drug to a 38-year-old woman who had turned to alcoholism to cope with her losing battle with breast cancer, which had spread to her bones.

Her physicians halted her cancer treatment and gave her Antabuse.

She lived for another 10 years before a drunken fall from a window killed her.

When they performed an autopsy, the doctors were shocked to find that while Antabuse had evidently not stopped the woman from drinking, the cancer cells had largely disappeared from her bones.

About the Common Constitutionalist

Brent, aka The Common Constitutionalist, is a Constitutional Conservative, and advocates for first principles, founders original intent and enemy of progressives. He is former Navy, Martial Arts expert. As well as publisher of the Common Constitutionalist blog, he also is a contributing writer for Political Outcast, Godfather Politics, Minute Men News (Liberty Alliance), Freedom Outpost, the Daily Caller, Vision To America and Free Republic. He also writes an exclusive weekly column for World Net Daily (WND).